GAPDH and metabolic dysfunction-associated steatotic liver disease: On the basis of these findings, we proposed a novel approach to alleviate NAFLD involves the suppression of methylglyoxal formation by increasing GAPDH, which maintains the anti-oxidation activity in the fatty liver.